Larvol Delta - Safety-and-tolerability-of-andecaliximab-as-monotherapy-and-in-combination-with-an-antiPD1-antibody-in-Japanese-patients-with-gastric-or-gastroesophageal-junction-adenocarcinoma-a-phase-1b-study

andecaliximab (GS-5745) - Gilead

Opdivo (nivolumab) - Ono Pharma, BMS

http://www.ncbi.nlm.nih.gov/pubmed/34992093

Jan 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next